Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Alcohol Use Complicates Chronic Disease Management in Teens

Will Boggs, MD  |  September 1, 2015

NEW YORK (Reuters Health)—High school students with chronic medical conditions who drink alcohol are more likely than their nondrinking peers to forget or skip taking their medications, according to an online survey.

“I was surprised to see such a clear association between alcohol use and medication nonadherence—a finding which really brings home the need to consider substance use risk within the context of disease management and specialty care,” Dr. Elissa R. Weitzman, from Boston Children’s Hospital, told Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

About a quarter of U.S. youth have a chronic medical condition, and alcohol and marijuana use is prevalent in this age group, but little has been known about how the use of these drugs influences their health and treatment outcomes.

Dr. Weitzman and colleagues used a browser-based survey to assess alcohol use knowledge, behaviors, and health care interactions, as well as marijuana use, in 403 youth (ages 9 to 18 years) who were receiving care for a chronic medical condition.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Almost a third of the entire sample (30.8%) and 36.5% of high school youth reported alcohol use in the past year. One-sixth of the entire sample (17.2%) and 20.6% of high school youth reported marijuana use in the past year.

Among high school youth, binge drinking was associated with better mental health, whereas marijuana use was negatively associated with mental health.

More than half of high school youth with diabetes, inflammatory bowel disease, arthritis, or cystic fibrosis correctly responded that alcohol can interfere with medications, and 37.2% answered correctly that it could interfere with laboratory test results. Only 27% answered both questions correctly, according to the Aug. 31 Pediatrics online report.

Youth who incorrectly answered the medication interaction question were 8.53 times as likely to drink and 4.46 times as likely to binge drink as youth who correctly answered that question.

High school youth who reported drinking in the past year were 79% more likely to report they forgot to take their medications and 61% more likely to report skipping their medications “always/often/sometimes” over the past 30 days, compared with youth who reported not drinking in the past year.

“We are in the infancy of studying this topic and have little information to guide us regarding the effectiveness of substance use prevention programs for youth with chronic illness,” Dr. Weitzman said.

“Having said that, the work we are doing suggests that this group of youth is deeply curious about these issues, desirous of factual and specific information about how alcohol and other substances affect their health and disease, and committed to being healthy and complication-free. This gives us a general landscape or topographical map on which to start building and testing models of preventive intervention for integration into care settings,” she added.

“Physicians should be aware that adolescents with chronic illnesses are using alcohol and other substances (they are not immune),” Dr. Weitzman concluded. “And, when they do, they are at considerably elevated risk for treatment nonadherence, which is a key predictor of poor disease outcomes. We strongly recommend screening these youth for alcohol and other substance use, and there are many excellent tools out there for structured screening.”

Kenneth Lee, from the University of California, Irvine, is a social science researcher who examines the links between education and health. He told Reuters Health by email, “From a social science researcher’s perspective, I would have liked to see if these findings hold up with a larger sample size, a longitudinal design, and more rigorous statistical methods that would reduce bias and take steps toward causality.”

“The more pressing issue for these adolescents is not a form of intervention but rather prevention—understanding where, when, and with whom adolescents are participating in substance use,” Lee said.

“My recently published paper shows that substance use in mid to late adolescence is strongly associated with different out-of-school time contexts and in particular, unsupervised time with peers. It is perhaps possible that reducing unsupervised time with peers in the out-of-school time environment may have positive impacts in reducing substance use,” he said.

The National Institutes of Health funded this study. The authors reported no disclosures.

Page: 1 2 | Multi-Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:AdolescentsAlcoholchronic conditiondruginflammatory bowel diseaseoutcome

Related Articles

    Cannabis in Rheumatology Care: A Look at the Latest Research & What Rheumatologists Are Telling Their Patients

    March 26, 2018

    As medical and recreational marijuana becomes more accessible, researchers seek creative ways to study the cannabis plant and explore the complexities of the endocannabinoid system in pain relief. Rheumatologists currently face an influx of patients asking if marijuana can help them. Here’s a look at the evolving research on cannabinoids for rheumatologic pain management and how doctors are discussing it with their patients…

    Rocketclips, Inc./shutterstock.com

    Tips for Managing Young Adult Rheumatology Patients

    May 18, 2017

    The clinician must be aware of the psychosocial challenges that inform their young patients’ perspectives on disease management. Rocketclips, Inc./shutterstock.com Often, young adults (18–23 years old) with rheumatic illness demonstrate poor adherence to treatment regimens, lack advocacy skills and have inadequate knowledge about diagnosis and treatment.1 Patients presenting at a transition clinic are typically comfortable…

    Would Legalizing Medical Marijuana Help Curb the Opioid Epidemic?

    March 28, 2017

    (Reuters Health)—In states that legalized medical marijuana, U.S. hospitals failed to see a predicted influx of pot smokers, but in an unexpected twist, they treated far fewer opioid users, a new study shows. Hospitalization rates for opioid painkiller dependence and abuse dropped on average 23% in states after marijuana was permitted for medicinal purposes, the…

    Medical Marijuana's Potential Benefits, Risks

    Medical Marijuana’s Potential Benefits, Risks

    July 12, 2016

    Brian Goodman/shutterstock.com CHICAGO—Despite the complicated politics surrounding medical marijuana, cannabis has a wide variety of medical benefits and potential benefits, but the risks need to be understood, said Daniel Clauw, MD, director of the Chronic Pain and Fatigue Research Center at the University of Michigan, in a session at the ACR’s 2016 State-of-the-Art Clinical Symposium….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences